Xiaodong Cheng, Ph.D.
Department of Epigenetics and Molecular Carcinogenesis, Division of VP, Research
Present Title & Affiliation
Primary Appointment
Professor, Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 8888 | Fudan University, Shanghai, CHN, BS, 1978-1982, Physics |
| 8888 | State University of New York, Stony Brook, NY, USA, PhD, 1984-1989, Protein Crystallography |
Postgraduate Training
| 1990-1991 | Postdoctoral, Protein Crystallography, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
Experience & Service
Academic Appointments
Professor, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2019
Administrative Appointments/Responsibilities
Co-Director, Department of Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Institutional Committee Activities
Reviewer, UT Stars Program, 2019 - Present
Member at-Large, Keck Executive Committee, 2017 - Present
Advisory, Core for Biomolecular Structure and Function, 2017 - 2020
Honors & Awards
| 2019 | Keynote, Symposium on Structural Biology (Van Andel Research Institute) |
| 2018 | Keynote, UNC Chromatin and Epigenetics Symposium (12/6/2018), University of North Carolina |
| 2015 | SER-CAT Outstanding Science Award |
| 2012 | AAAS Fellow Elected |
| 2008 | Albert E. Levy Awards for Excellence in Scientific Research |
| 1997 | Visiting Professorship, Max-Planck Institute fur Molecular Genetik |
Grant & Contract Support
| Title: | Histone Lysine deMethylation: Structures, Inhibitions and Mechanisms |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | DNA Methylation: Structures, Functions, and Regulation |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | CPRIT Established Investigator Award |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Principal Investigator |
| Title: | Cell therapy for diabetic peripheral neurovascular complications |
| Funding Source: | NIH/NIDDK |
| Role: | Co-Principal Investigator |
| Title: | Novel 5-methylcytosine oxidases |
| Funding Source: | NIH/NIGMS |
| Role: | Co-Investigator |
| Title: | Histone Demethylases (KDM5A/KDM5B) |
| Funding Source: | Leidos Biomedical Research |
| Role: | Co-Investigator |
| Title: | DNA Methylation: Structures, Functions, and Regulation |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | Histone Lysine Methylation: Structures and Functions |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | Novel 5-hydroxymethylcytosine specific enzymes for epigenetic studies |
| Funding Source: | NIH/NIGMS |
| Role: | Co-Investigator |
| Title: | Novel enzyme reagents for epigenetic studies |
| Funding Source: | NIH/NIGMS |
| Role: | Co-Investigator |
| Title: | Generation of induced pluripotent stem cells with novel small molecule |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | ARRA Supplementary (Equipment) |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | ARRA Supplementary (Equipment) |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | Identification and characterization of novel epigenetic marks of non-histone |
| Funding Source: | NIH/NIDDK |
| Role: | Principal Investigator |
| Title: | (ARRA Supplement: summer students) |
| Funding Source: | NIH/NIDDK |
| Role: | Principal Investigator |
| Title: | (ARRA Supplement: equipment) |
| Funding Source: | NIH/NIDDK |
| Role: | Principal Investigator |
| Title: | Administrative supplements for induced Pluripotent Stem Cell Research |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | Epigenetic regulations of DNA and histone methylation and deMethylation: Structures and Mechanisms |
| Funding Source: | NIH/NIGMS |
| Role: | Principal Investigator |
| Title: | Cancer Genetics and Epigenetics – Program 25 |
| Funding Source: | NIH/NIDDK |
| Role: | Program Director |
| Title: | Targeting the complexity of TRIM28 repressor complex in tumor |
| Funding Source: | Tobacco Grant, The University of Texas MD Anderson Cancer Center |
| Role: | Principal Investigator |